Form 4: Nu Skin Director Sells 6,489 Shares Under 10b5-1 Plan

Nu Skin Enterprises Director Laura Nathanson sold 6,489 shares of Class A Common Stock for $12.22 per share on September 4, 2025, under a pre-arranged 10b5-1 plan.

Summary

• Laura Nathanson, a Director of Nu Skin Enterprises, Inc. (NUS), sold 6,489 shares of Class A Common Stock.
• The transaction occurred on September 4, 2025, at a price of $12.22 per share.
• The sale was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following this transaction, Ms. Nathanson directly beneficially owns 33,149 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The sale by a director, Laura Nathanson, is a reduction in insider ownership. However, the transaction was conducted under a pre-arranged 10b5-1 plan, which suggests it is a scheduled liquidity event rather than a reaction to new, negative information. This makes the sentiment neutral, as it's not an unexpected event but still a reduction in insider holdings.

Positives

• The sale was conducted under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on new, non-public information.

Negatives

• A director selling shares, even under a 10b5-1 plan, reduces their direct ownership in the company.

Future Outlook

No future outlook or guidance is provided in this filing.

Industry Context

This Form 4 filing primarily reports an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: A director's sale, even when pre-planned, can sometimes be perceived as a slight reduction in insider confidence, though the 10b5-1 plan mitigates significant negative interpretation.

Key Dates

Recommendation

The Form 4 reports a routine, pre-scheduled sale of a relatively small number of shares by a director under a 10b5-1 plan. This transaction does not provide new fundamental insights into Nu Skin's operational performance or strategic direction that would warrant a change in investment recommendation. Investors should maintain their current position and focus on the company's financial reports and broader market conditions for investment decisions.

Keywords

Nu Skin Enterprises, NUS, Laura Nathanson, Director, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, Equity Sale